4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-25-001825
CHIEF COMMERCIAL OFFICER sold 30,598 shares at an average $37.51 ($1,147,715)
- CHIEF COMMERCIAL OFFICER acquired 30,598 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-16 | Option exercise 10b5-1 | +29,475 | $33.44 | $985,644 | 29,475 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-16 | Sale 10b5-1 | −29,475 | $37.41 | $1,102,795 | 0 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-21 | Option exercise 10b5-1 | +1,123 | $33.44 | $37,553 | 1,123 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-21 | Sale 10b5-1 | −1,123 | $40.00 | $44,920 | 0 | D |
| Derivatives | |||||||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-16 | Option exercise · Stock Option 10b5-1 | −29,475 | 6,738 | D | ||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-21 | Option exercise · Stock Option 10b5-1 | −1,123 | 5,615 | D | ||
| Open-market sales · 30,598 sh · avg $37.51 · $1,147,715 | |||||||
Loading xslF345X05/form4-01222025_010141.xml…